Lisa Kachnic named chair of Columbia Department of Radiation Oncology, chief of Radiation Oncology Service at NY-Presbyterian/Columbia University Irving Medical Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Lisa Kachnic was named chair of the Department of Radiation Oncology at the Columbia University Vagelos College of Physicians and Surgeons and chief of the radiation oncology service at New York-Presbyterian/Columbia University Irving Medical Center effective Sept. 1. She will also serve as associate director for Cancer Network Strategy in the Herbert Irving Comprehensive Cancer Center.

Kachnic is currently a professor and chair of the Department of Radiation Oncology at the Vanderbilt University School of Medicine. She previously served on the radiation oncology faculty at Massachusetts General Hospital and Boston University School of Medicine. She is a fellow of the American Society for Radiation Oncology.

A past president and current governor of the American Board of Radiology, Kachnic is the vice chair of the radiation oncology committee and co-chair of the ano-rectal subcommittee for the SWOG Cancer Research Network research base, where she serves as the multi-modality executive officer. Kachnic is also the chair of the NRG Oncology, NCI Community Oncology Research Program’s Cancer Control and Prevention Division, and is involved in NRG Oncology’s GI strategic committee.

Table of Contents

YOU MAY BE INTERESTED IN

A year ago, when he was sworn in as director of the National Cancer Institute, Anthony G. Letai set a goal: Reassure cancer researchers that the institute will keep a steady course aimed at finding treatments for cancer.
Michael R. Caputo, a cancer survivor and a Republican political operative with a wide-ranging resume, was named to the President’s Cancer Panel, a board formed under the National Cancer Act to monitor the National Cancer Program and report to the president about “barriers to progress in reducing the burden of cancer.”
For over two decades, the ASCO Genitourinary Cancers Symposiumhas stood as the premier global event that has helped advance cancer science and transform care. The 2027 Symposium will continue this legacy from Feb. 11–13 in San Francisco by bringing together the largest international audience in GU oncology to help define tomorrow’s standards of care. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login